Dysferlin interacts with tubulin and microtubules in mouse skeletal muscle
- PMID: 20405035
- PMCID: PMC2853571
- DOI: 10.1371/journal.pone.0010122
Dysferlin interacts with tubulin and microtubules in mouse skeletal muscle
Abstract
Dysferlin is a type II transmembrane protein implicated in surface membrane repair in muscle. Mutations in dysferlin lead to limb girdle muscular dystrophy 2B, Miyoshi Myopathy and distal anterior compartment myopathy. Dysferlin's mode of action is not well understood and only a few protein binding partners have thus far been identified. Using affinity purification followed by liquid chromatography/mass spectrometry, we identified alpha-tubulin as a novel binding partner for dysferlin. The association between dysferlin and alpha-tubulin, as well as between dysferlin and microtubules, was confirmed in vitro by glutathione S-transferase pulldown and microtubule binding assays. These interactions were confirmed in vivo by co-immunoprecipitation. Confocal microscopy revealed that dysferlin and alpha-tubulin co-localized in the perinuclear region and in vesicular structures in myoblasts, and along thin longitudinal structures reminiscent of microtubules in myotubes. We mapped dysferlin's alpha-tubulin-binding region to its C2A and C2B domains. Modulation of calcium levels did not affect dysferlin binding to alpha-tubulin, suggesting that this interaction is calcium-independent. Our studies identified a new binding partner for dysferlin and suggest a role for microtubules in dysferlin trafficking to the sarcolemma.
Conflict of interest statement
Figures







Similar articles
-
The C2 domains of dysferlin: roles in membrane localization, Ca2+ signalling and sarcolemmal repair.J Physiol. 2022 Apr;600(8):1953-1968. doi: 10.1113/JP282648. Epub 2022 Mar 8. J Physiol. 2022. PMID: 35156706 Free PMC article.
-
Dysferlin interacts with histone deacetylase 6 and increases alpha-tubulin acetylation.PLoS One. 2011;6(12):e28563. doi: 10.1371/journal.pone.0028563. Epub 2011 Dec 8. PLoS One. 2011. Retraction in: PLoS One. 2018 Jan 29;13(1):e0192239. doi: 10.1371/journal.pone.0192239. PMID: 22174839 Free PMC article. Retracted.
-
Proteomic analysis of the dysferlin protein complex unveils its importance for sarcolemmal maintenance and integrity.PLoS One. 2010 Nov 5;5(11):e13854. doi: 10.1371/journal.pone.0013854. PLoS One. 2010. PMID: 21079765 Free PMC article.
-
On the role of dysferlin in striated muscle: membrane repair, t-tubules and Ca2+ handling.J Physiol. 2024 May;602(9):1893-1910. doi: 10.1113/JP285103. Epub 2024 Apr 14. J Physiol. 2024. PMID: 38615232 Review.
-
Ferlin proteins in myoblast fusion and muscle growth.Curr Top Dev Biol. 2011;96:203-30. doi: 10.1016/B978-0-12-385940-2.00008-5. Curr Top Dev Biol. 2011. PMID: 21621072 Free PMC article. Review.
Cited by
-
Muscle membrane repair and inflammatory attack in dysferlinopathy.Skelet Muscle. 2011 Mar 1;1(1):10. doi: 10.1186/2044-5040-1-10. Skelet Muscle. 2011. PMID: 21798087 Free PMC article.
-
Contribution of Extracellular Vesicles in Rebuilding Injured Muscles.Front Physiol. 2019 Jul 18;10:828. doi: 10.3389/fphys.2019.00828. eCollection 2019. Front Physiol. 2019. PMID: 31379590 Free PMC article. Review.
-
The Dysferlinopathies Conundrum: Clinical Spectra, Disease Mechanism and Genetic Approaches for Treatments.Biomolecules. 2024 Feb 21;14(3):256. doi: 10.3390/biom14030256. Biomolecules. 2024. PMID: 38540676 Free PMC article. Review.
-
Proteasomal inhibition restores biological function of mis-sense mutated dysferlin in patient-derived muscle cells.J Biol Chem. 2012 Mar 23;287(13):10344-10354. doi: 10.1074/jbc.M111.329078. Epub 2012 Feb 8. J Biol Chem. 2012. Retraction in: J Biol Chem. 2017 Jul 28;292(30):12542. doi: 10.1074/jbc.A111.329078. PMID: 22318734 Free PMC article. Retracted.
-
Identification of Novel Antisense-Mediated Exon Skipping Targets in DYSF for Therapeutic Treatment of Dysferlinopathy.Mol Ther Nucleic Acids. 2018 Dec 7;13:596-604. doi: 10.1016/j.omtn.2018.10.004. Epub 2018 Oct 11. Mol Ther Nucleic Acids. 2018. PMID: 30439648 Free PMC article.
References
-
- Bashir R, Britton S, Strachan T, Keers S, Vafiadaki E, et al. A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B. Nat Genet. 1998;20:37–42. - PubMed
-
- Liu J, Aoki M, Illa I, Wu C, Fardeau M, et al. Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet. 1998;20:31–36. - PubMed
-
- Illa I, Serrano-Munuera C, Gallardo E, Lasa A, Rojas-Garcia R, et al. Distal anterior compartment myopathy: a dysferlin mutation causing a new muscular dystrophy phenotype. Ann Neurol. 2001;49:130–134. - PubMed
-
- Therrien C, Dodig D, Karpati G, Sinnreich M. Mutation impact on dysferlin inferred from database analysis and computer-based structural predictions. Journal of the Neurological Sciences. 2006;250:71–78. - PubMed
-
- Vandre DD, Ackerman WEt, Kniss DA, Tewari AK, Mori M, et al. Dysferlin is expressed in human placenta but does not associate with caveolin. Biol Reprod. 2007;77:533–542. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases